No. 1 is SCBASHARE(SSFE) +5.69%
TISCO China Strategy Fund
Shows where this fund stands in its group. Not investment advice · Data as of 4 Nov 2026
TCHSTRATEGY is a fund of funds that puts 99.08% into units of other funds, spread across several funds
This fund's manager selects the funds and adjusts their weights. The funds it holds also charge their own fees
Over the past year it was in the top 25% of its group; over 3 years it returned +9.18% per year (Top 25% of the group)
No. 1 is SCBASHARE(SSFE) +5.69%
Each bar is one fund in the AIMC China Equity - A Shares group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 4 Nov 2026
Past performance is not a guarantee of future results
| YTD | 1W | 2W | 1M | 3M | 6M | 1Y | 3Y | MAX |
|---|---|---|---|---|---|---|---|---|
| +5.53% | +6.30% | +5.42% | −4.84% | −9.67% | −4.02% | +3.09% | +30.19% | −15.26% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar |
|---|
Largest drawdown in the selected period −48.56% Previous peak 17 Aug 2022 (NAV 10.0743) → Trough 13 Sep 2024 (NAV 5.1826) · Back to the previous peak on 25 Jun 2026, after 1 year 9 months
Currently −20.77% from the peak NAV of 10.7029 (1 Jul 2026)
Over 3 years, TCHSTRATEGY returned 0.31 per unit of volatility, ranking 8 of 23 funds · The highest is B-CHINAARMF (0.47)
กองทุนจะลงทุนในหรือมีไว้ซึ่งหน่วยลงทุนของกองทุนรวมตราสารทุนต่างประเทศ และ/หรือกองทุนรวมอีทีเอฟตราสารทุนต่างประเทศ ที่มีนโยบายการลงทุนในหลักทรัพย์หรือตราสารทุนของบริษัทที่มีความเกี่ยวข้องกับอุตสาหกรรมที่ได้รับประโยชน์จากแผนพัฒนาเศรษฐกิจและสังคมแห่งชาติของประเทศจีน ซึ่งมีวัตถุประสงค์เพื่อกำหนดยุทธศาสต… Its largest holdings are GLOBAL X CHINA BIOTECH ETF 37.68% · GLOBAL X CHINA SEMICONDUCTOR ETF 26.96% · GLOBAL X CHINA CLEAN ENERGY ETF 18.55% (fact sheet 30 Sep 2026)
Risk level 6 of 8 (High risk). Since 10 Aug 2022, its NAV has fallen as much as −48.56% from its peak.
Actual total expense ratio (TER) 1.73% a year, against a ceiling of 5.00%. Management fee 1.61%. Front-end fee 1.25%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
All funds, as disclosed in the AMC fact sheet · The stocks these funds hold are shown below · This fund's performance therefore depends on the funds it holds
Chinese company that develops and makes biologic drugs such as antibodies for drug companies worldwide
Chinese company that researches, tests and makes drugs under contract for drug and biotech companies worldwide
Biotech formerly BeiGene that develops cancer drugs such as Brukinsa for lymphoma
Chinese biotech developing cancer drug Tyvyt and the diabetes and weight loss drug mazdutide
Chinese company that designs AI chips for data centres, an alternative to Nvidia chips in China
Hospitals, medicines and medical equipment
Mobile networks, internet and software
Chinese company ChangXin Memory that makes DRAM memory chips for phones, computers and servers
Chinese biotech company developing antibody drugs for cancer and immune diseases, such as ivonescimab
Based on each ETF's actual share of the fund's value · Weighted by each fund held × the stocks that fund holds, covering 100% of the money invested in other funds. Uses each fund's top 10, so figures are a minimum · Global X China Biotech as of 27 Oct 2026 · Global X China Semiconductor as of 27 Oct 2026 · Global X China Clean Energy as of 27 Oct 2026 · Global X China Consumer Brand as of 31 Aug 2026 · Illustrations are for explanation only, not individual stock recommendations
No. 1 is UCI-SSF +12.83% per year
| Apr |
|---|
| May |
|---|
| Jun |
|---|
| Jul |
|---|
| Aug |
|---|
| Sep |
|---|
| Oct |
|---|
| Nov |
|---|
| Dec |
|---|
| Full year |
|---|
| 2026 | +6.6 | +2.5 | −9.5 | +10.5 | +7.9 | +12.9 | −13.9 | +1.3 | −2.5 | −13.5 | +7.7 | · | +5.5* |
| 2025 | −3.8 | +6.9 | −0.3 | −2.3 | +2.3 | +3.8 | +9.2 | +11.5 | +7.2 | −4.5 | −4.1 | +0.8 | +28.2 |
| 2024 | −14.9 | +13.2 | −1.7 | +1.5 | −4.6 | −4.1 | +1.4 | −2.7 | +21.0 | −1.0 | −1.9 | −1.8 | −0.1 |
| 2023 | +8.8 | −7.8 | −0.5 | −5.2 | −9.1 | −0.0 | +1.3 | −9.2 | −1.6 | −3.6 | +0.1 | −3.1 | −27.2 |
| 2022 | · | · | · | · | · | · | · | −5.3 | −11.4 | −8.6 | +11.1 | +1.1 | −13.9* |
Minimum first purchase 1,000 THB, subsequent purchases 1,000 THB. Buy orders accepted until 15:00, sell orders until 15:00, and redemption proceeds are paid T+4
Hedged at the manager's discretion. As of 30 Sep 2026, 86.42% of the value of its foreign investments was hedged
Chinese company that makes etching and deposition machines for chip factories